- Do you want to ensure that you never have a surprise regulatory inspection outcome?
- The equation incorporates all you need to assess the status of your site and is even better for companies with networks of sites
- Data integrity, quality culture, process capability, management commitment and Quality Management Systems are all assessed to produce actionable data whether you are overseeing a CMO or operate your own network of sites
—
Brandon Varnau
Head, Industrial Affairs Specialty Care Global Business Unit Quality Operations
Sanofi
Brandon Varnau is Head of Industrial Affairs Specialty Care Global Business Unit Quality Operations for Sanofi. He utilizes 30 years of experience in Biologics to lead all aspects of Quality Assurance, Quality Control and Compliance for eight Biologics sites in the US and EU. He also leads corporate quality and quality oversight over 35 CMOs and has successfully licensed many new biological products. Specialty Care currently has over 50 commercial products representing over $14 billion in revenue for Sanofi. Prior to his current position, Brandon was Vice President Operations Quality and prior to this he was Vice President of Quality at Genzyme’s Allston plant where Brandon joined Genzyme in 2011 just after this site received a FDA consent decree. Prior to Genzyme, Brandon was Vice President of Quality for Bayer Health Care.